Roth Iris - Insider Non-Derivative Transactions at Zentalis Pharmaceuticals, Inc. (ZNTL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 1, 2023, Roth Iris's relationship to Zentalis Pharmaceuticals, Inc. (ZNTL) is Officer (Chief Operating Officer), and currently has 52,500 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ZNTL insiders.
Data Source: SEC.
Roth Iris - Insider Non-Derivative Transactions at ZNTL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 2, 2023 | Acquisition -- (Common Stock) | 52500 | 0 | 52500 |